Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: This spontaneous report as received from a consumer (mother of the patient) refers to a 15 year old female patient. Patient''s medical history and concurrent conditions was not reported. On 08-AUG-2013 the patient was vaccinated with GARDASIL (reported as GARDASIL INJ 120 Y) Strength 120MCG, dose 1. Concomitant therapies included ALLEGRA. On an unknown date in November 2012 the patient experienced migraine headaches. On an unknown date the patient experienced chronic fatigue, is missing a lot of school due to her not feeling well (disability), is having difficulty in school and her grades are dropping, can''t focus, is sensitive to light and noise, nauseous, feels dizzy, has her period every 2 weeks, low blood pressure, fainted, vision problems (double vision), and neck pain. The reporter stated that her daughter''s migraine headaches started on an unspecified date in November 2013 and lasted for 4 days. The patient had a second migraine headache in February 2014. The reporter also stated that the patient was a swimmer and used to swim 4 hours per day and was in good health prior to receiving GARDASIL. The reporter stated that the patient had fainted and had an irregular EKG after fainting. The patient''s second EKG was normal. It was reported that in November 2013 the CT of Brain done by the neurologist was normal. The patient was treated for the adverse events with cyproheptadine and Ondansetron. The outcome of the events was unknown. The reporter''s causality assessment was not provided. The patient developed severe stomach problems, hyperthyroidism and early menopause after taking VIOXX (MARRS ID 1404USA014704). Additional information has been requested.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166